American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity

American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity

Four major medical societies involved with hydroxychloroquine (HCQ) therapy concur on the need for common principles and cooperation to minimize the risk of ocular toxicity. At a daily dosage of ≤5 mg/kg/day actual body weight, the risk of retinal toxicity from HCQ is

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2021-06, Vol.73 (6), p.908-911
Hauptverfasser: Rosenbaum, James T., Costenbader, Karen H., Desmarais, Julianna, Ginzler, Ellen M., Fett, Nicole, Goodman, Susan M., O’Dell, James R., Schmajuk, Gabriela, Werth, Victoria P., Melles, Ronald B., Marmor, Michael F.
Format: Artikel
Sprache:eng
Schlagworte:
Body weight
Dermatology
Dosage
Eye
Hydroxychloroquine
Ophthalmology
Patients
Physicians
Retina
Sensitivity analysis
Toxicity
Visual fields
Visual perception
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Four major medical societies involved with hydroxychloroquine (HCQ) therapy concur on the need for common principles and cooperation to minimize the risk of ocular toxicity. At a daily dosage of ≤5 mg/kg/day actual body weight, the risk of retinal toxicity from HCQ is
ISSN:2326-5191
2326-5205
DOI:10.1002/art.41683